Observational Study of Immune System Related Kidney Disease

This study is looking at kidney diseases that are caused by problems with the immune system, such as nephrotic syndrome, glomerulonephritis, membranous nephropathy, and lupus nephritis. Researchers want to understand more about what causes these conditions and the specific changes they create in the body. You could be eligible if you are between 10 and 99 years old and have a known or suspected immune-related kidney disease. The main goal is to collect blood and urine samples, along with information from your standard medical care, to help researchers learn more about these conditions and develop future studies. This study is ongoing and aims to enroll 2000 participants.

Study design
This is an observational study, meaning researchers will collect information and samples from 2000 participants over time without providing specific treatments.
What's involved
You would provide blood and urine samples, and information from your standard medical care would be collected.
Compensation
Not stated in the trial record.
Follow-up
Biospecimens will be collected on an ongoing basis.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00001979

Immune System Related Kidney Disease

Recruiting
Not specifiedAges 10–99Observational
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
~2,000 participants
Updated 2026-08-28 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Provision of biospecimens
Measured over ongoing
Kidney Disease
Nephrotic Syndrome
1 sites across 1 states
Maryland1
  • Meryl A Waldman, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Opens a ready-to-send draft in your own email app — review before sending.

  • Provision of biospecimensongoing

    Patients with autoimmune diseases for whom there are no current experimental treatment protocols can be admitted for study and follow-up; they will provide a ready pool of candidates who can be asked to provide blood specimens for ongoing laboratory studies.